全文获取类型
收费全文 | 7981篇 |
免费 | 580篇 |
国内免费 | 159篇 |
专业分类
耳鼻咽喉 | 45篇 |
儿科学 | 229篇 |
妇产科学 | 119篇 |
基础医学 | 1449篇 |
口腔科学 | 102篇 |
临床医学 | 389篇 |
内科学 | 1185篇 |
皮肤病学 | 138篇 |
神经病学 | 726篇 |
特种医学 | 336篇 |
外科学 | 1223篇 |
综合类 | 529篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 259篇 |
眼科学 | 64篇 |
药学 | 982篇 |
1篇 | |
中国医学 | 214篇 |
肿瘤学 | 728篇 |
出版年
2023年 | 105篇 |
2022年 | 158篇 |
2021年 | 251篇 |
2020年 | 197篇 |
2019年 | 307篇 |
2018年 | 278篇 |
2017年 | 215篇 |
2016年 | 208篇 |
2015年 | 231篇 |
2014年 | 440篇 |
2013年 | 469篇 |
2012年 | 358篇 |
2011年 | 472篇 |
2010年 | 399篇 |
2009年 | 432篇 |
2008年 | 415篇 |
2007年 | 418篇 |
2006年 | 431篇 |
2005年 | 370篇 |
2004年 | 321篇 |
2003年 | 276篇 |
2002年 | 233篇 |
2001年 | 172篇 |
2000年 | 152篇 |
1999年 | 113篇 |
1998年 | 121篇 |
1997年 | 105篇 |
1996年 | 157篇 |
1995年 | 79篇 |
1994年 | 62篇 |
1993年 | 51篇 |
1992年 | 60篇 |
1991年 | 38篇 |
1990年 | 22篇 |
1989年 | 26篇 |
1988年 | 19篇 |
1986年 | 27篇 |
1985年 | 56篇 |
1984年 | 61篇 |
1983年 | 43篇 |
1982年 | 61篇 |
1981年 | 41篇 |
1980年 | 43篇 |
1979年 | 35篇 |
1978年 | 35篇 |
1977年 | 23篇 |
1976年 | 33篇 |
1975年 | 25篇 |
1974年 | 19篇 |
1973年 | 15篇 |
排序方式: 共有8720条查询结果,搜索用时 15 毫秒
41.
A novel STK11 germline mutation in two siblings with Peutz-Jeghers syndrome complicated by primary gastric cancer 总被引:1,自引:0,他引:1
Shinmura K Goto M Tao H Shimizu S Otsuki Y Kobayashi H Ushida S Suzuki K Tsuneyoshi T Sugimura H 《Clinical genetics》2005,67(1):81-86
Patients with Peutz-Jeghers syndrome (PJS) are known to be at risk of gastric cancer (GC), and the STK11 gene is a susceptibility gene for PJS. However, as no cases of PJS with GC in which a STK11 germline mutation has been identified have ever been reported and other susceptibility genes have also been suggested to be involved in PJS, the relation between STK11 germline mutations and GC in PJS is still unknown. In this study, we used sequencing analysis to investigate the STK11, CDH1, and TP53 loci for a germline mutation in two siblings with PJS with primary GC. A novel type of the STK11 germline mutation, c.890delG, encoding a truncated protein (p.Arg297fsX38) was identified, but no germline mutations of the CDH1 and TP53 genes were detected. No inactivation of the wild-type allele by somatic mutation or chromosomal deletion or hypermethylation at the 5'-CpG site of STK11 was detected in the GC. This is the first report of a STK11 germline mutation in a PJS patient with GC and should contribute to establishing correlations between the STK11 germline mutations and GC in PJS patients. 相似文献
42.
Massa O Iafusco D D'Amato E Gloyn AL Hattersley AT Pasquino B Tonini G Dammacco F Zanette G Meschi F Porzio O Bottazzo G Crinó A Lorini R Cerutti F Vanelli M Barbetti F;Early Onset Diabetes Study Group of the Italian Society of Pediatric Endocrinology Diabetology 《Human mutation》2005,25(1):22-27
Permanent neonatal diabetes mellitus (PNDM) is a rare condition characterized by severe hyperglycemia constantly requiring insulin treatment from its onset. Complete deficiency of glucokinase (GCK) can cause PNDM; however, the genetic etiology is unknown in most PNDM patients. Recently, heterozygous activating mutations of KCNJ11, encoding Kir6.2, the pore forming subunit of the ATP-dependent potassium (K(ATP)) channel of the pancreatic beta-cell, were found in patients with PNDM. Closure of the K(ATP) channel exerts a pivotal role in insulin secretion by modifying the resting membrane potential that leads to insulin exocytosis. We screened the KCNJ11 gene in 12 Italian patients with PNDM (onset within 3 months from birth) and in six patients with non-autoimmune, insulin-requiring diabetes diagnosed during the first year of life. Five different heterozygous mutations were identified: c.149G>C (p.R50P), c.175G>A (p.V59M), c.509A>G (p.K170R), c.510G>C (p.K170N), and c.601C>T (p.R201C) in eight patients with diabetes diagnosed between day 3 and 182. Mutations at Arg50 and Lys170 residues are novel. Four patients also presented with motor and/or developmental delay as previously reported. We conclude that KCNJ11 mutations are a common cause of PNDM either in isolation or associated with developmental delay. Permanent diabetes of non autoimmune origin can present up to 6 months from birth in individuals with KCNJ11 and EIF2AK3 mutations. Therefore, we suggest that the acronym PNDM be replaced with the more comprehensive permanent diabetes mellitus of infancy (PDMI), linking it to the gene product (e.g., GCK-PDMI, KCNJ11-PDMI) to avoid confusion between patients with early-onset, autoimmune type 1 diabetes. 相似文献
43.
Yuichi Nakagawa Hiromi Takeuchi Akira Kubota Yutaka Nakahori Yasuo Nakagome Yoshio Igarashi Masao Yamada 《Journal of human genetics》1993,38(2):203-207
Summary Restriction fragment length polymorphisms (RFLPs) of the CYP11B1 gene were studied in Japanese using cDNA clone P450c11 as a probe. Genomic DNAs from 60 unrelated Japanese individuals were digested with 8 different restriction enzymes and analyzed by Southern blot hybridization. Two RFLPs were detected inMspI digests of the DNA. One(A) was characterized by polymorphic bands at 3.4 and 2.5 kilobasepairs (kb) and the other (B) by polymorphic bands at 1.7 and 1.2 kb. The third RFLP was observed inPvuII-digested samples and was polymorphic at 5.8 and 4.0 kb bands. Two of the three RFLPs found, RFLP (A) and (C), have not been described in the only previous report which was based on Caucasian samples. We also examined the RFLPs of a 3 generation family of 11-hydroxylase deficiency caused by an abnormality of the CYP11B1 gene. All the family members were homozygous in all three RFLPs and was thus not informative. 相似文献
44.
Agneta Nordberg Anders Lilja Hans Lundqvist Per Hartvig Kaarina Amberla Matti Viitanen Ulrika Warpman Monika Johansson Ewa Hellstrm-Lindahl Peter Bjurling Karl-Johan Fasth Bengt Lngstrm Bengt Winblad 《Neurobiology of aging》1992,13(6):747-758
Three patients with Alzheimer's disease, a 68-year-old woman with mild dementia and 2 men (aged 64 and 72 years) with moderate dementia were treated orally with the cholinesterase inhibitor tacrine (tetrahydroaminoacridine), 80 mg daily, for several months. The patients were investigated using positron emission tomography (PET) prior to, and after 3 weeks and 3 months of treatment. The PET studies involved a multi-tracer system consisting of [18F]-fluoro-deoxy-glucose (18F-FDG) (tracer for glucose metabolism); 11C-butanol (cerebral blood flow) and (S)(−)- and (R)(+)-[N-11C-methyl]-nicotine (nicotinic receptors; cholinergic neural activity). Tacrine treatment increased the uptake of 11C-nicotine to the brain. Significant reduced difference in uptake between the two enantiomers (S)(−)- and (R)(+)11C-nicotine was observed in the frontal and temporal cortices after tacrine treatment in all three patients. The kinetic analysis indicated increased binding of (S)(−)11C-nicotine in brain compatible with a restoration of nicotinic cholinergic receptors. The most pronounced effect was observed after 3 weeks and 3 months treatment in the patient with mild dementia. An increase in cerebral glucose utilization was found in the 68-year-old patient with mild dementia but also slightly in the 64-year-old man with moderate dementia when treated with tacrine for 3 months. Tacrine administration did not affect cerebral blood flow. The PET data obtained after 3 weeks of tacrine treatment was paralleled by improvement in neuropsychological performance. This study shows in vivo by PET neurochemical effects induced in brain by treatment with tacrine to Alzheimer patients. Intervention with tacrine in the early course of the disease might be necessary for clinical improvement. 相似文献
45.
目的:构建幽门螺杆菌(Hp)UreB-Omp11融合蛋白的重组疫苗候选株,在大肠杆菌中表达UreB-Omp11融合蛋白,并检测其免疫学活性。方法:用PCR方法扩增郑州分离Hp菌株MEL-HP27的ureB和omp11基因并用重叠延伸PCR法获得ureB-omp11融合基因,将融合基因ureB-omp11插入原核表达载体pET30a( )、pET28a( )及pMAL-c2X中,筛选出合适的表达系统并进行融合蛋白的表达,采用Western blot对表达产物进行鉴定,并用Amylose亲和层析法纯化融合蛋白,应用SDS-PAGE方法对纯化产物进行分析,纯化的融合蛋白辅以免疫佐剂皮下免疫小鼠,Western blot对免疫小鼠血清进行检测。结果:特异PCR法、酶切鉴定并经测序分析后证实融合基因ureB-omp11克隆入表达载体pET30a( )、pET28a( )与pMAL-c2X中;重组菌TB1(pMAL-ureB-omp11)经诱导获得了高效表达的MBP-UreB-Omp11融合蛋白,该融合蛋白可以被Hp免疫小鼠血清和Hp阳性患者血清中的相应抗体所识别,纯化后的融合蛋白纯度达90%以上。通过大肠杆菌抗原吸收法纯化免疫小鼠血清后,与纯化的融合蛋白进行杂交,结果显示在Mr134000处出现特异杂交带,融合蛋白具有良好的免疫原性和免疫反应性。结论:成功地构建并筛选出了HpMELHP27融合蛋白UreB-Omp11的重组疫苗候选株TB1(pMAL-ureB-omp11),为Hp蛋白质疫苗和核酸疫苗的研制奠定了基础。 相似文献
46.
47.
目的研究人染色体11p15.5Beckwith-Wiedemann综合征致病位点新基因C11orf21的生物学功能。方法用RT-PCR和Northern印记方法分析C11orf21基因的表达;研究C11orf21蛋白功能用Western印记和细胞培养方法。结果检测到C11orf21基因在成人和胎儿心脏和肝脏等组织转录,在心脏有较强的表达并有0.9和3.1kb两个转录物。C11orf21蛋白在COS-1和Hela细胞细胞质表达,蛋白相对分子质量为14kDa。结论初步分析显示C11orf21是11p15.5Beckwith-Wiedemann综合征致病位点的一个非印记基因,在成人心脏有较强表达的局限细胞质蛋白。 相似文献
48.
Florence P. Haseltine Vincent A. Lynch Daniel L. Van Dyke W. Roy Breg Uta Francke John M. Opitz 《American journal of medical genetics. Part A》1982,13(2):115-123
Cells from three patients with early gonadal failure and a balanced reciprocal translocation involving the long arm of the X chromosome and an autosome were studied. Fibroblasts from a patient with a similar balanced reciprocal translocation but normal reproductive capabilities were also studied. Two of the four patients were found to have serologically detectable H-Y antigen on their cells. Since H-Y antigen has been found on the cells of other patients with X chromosome abnormalities but without a Y chromosome, it is thought that the X chromosome plays a role in the regulation of H-Y antigen expression. This study suggests that the long arm of the X chromosome may be involved but the location of a regulatory gene cannot be identified in these studies. These cases do not permit us to implicate H-Y antigen as a cause of gonadal dysgenesis and early gonadal failure in females who have structurally abnormal X chromosomes. 相似文献
49.
Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis 总被引:13,自引:0,他引:13
Döhner H Stilgenbauer S Döhner K Bentz M Lichter P 《Journal of molecular medicine (Berlin, Germany)》1999,77(2):266-281
In B-cell chronic lymphocytic leukemia (B-CLL) clonal chromosome aberrations are detected in approximately 40–50% of tumors
when using conventional chromosome banding analysis. Most studies find trisomy 12 to be the most frequent chromosome aberration,
followed by structural aberrations of the long arm of chromosomes 13 and 14. Trisomy 12 and the ”14q+” marker are associated
with shorter survival times, while the patients with 13q abnormalities have a favorable outcome, similar to those with a normal
karyotype. The development of molecular cytogenetic techniques has greatly improved our ability to detect chromosome aberrations
in tumor cells. Using fluorescence in situ hybridization, chromosome aberrations can be detected not only in dividing cells
but also in interphase nuclei, an approach referred to as interphase cytogenetics. The prevalence of specific aberrations in B-CLL is currently being reassessed by interphase cytogenetics. By far the most
frequent abnormality are deletions involving chromosome band 13q14, followed by deletions of the genomic region 11q22.3-q23.1,
trisomy 12, deletions of 6q21-q23, and deletions/mutations of the TP53 tumor suppressor gene at 17p13. The evaluation of the true incidence of these aberrations now provides the basis for more
accurate correlations with clinical characteristics and outcome. Deletions/mutations of the TP53 gene have been shown to be associated with resistance to treatment and to be an independent marker for poor survival. 11q
deletions have been associated with extensive nodal involvement, rapid disease progression, and short survival times. Whether
trisomy 12, 13q14, and 6q deletions have a prognostic impact awaits further study. The application of these molecular cytogenetic
techniques will also contribute to the identification of the pathogenetically relevant genes that are affected by the chromosome
aberrations in B-CLL.
Received: 2 February 1998 / Accepted: 31 March 1998 相似文献
50.
Aidan P. McManus Barry A. Gusterson C. Ross Pinkerton Janet M. Shipley 《The Journal of pathology》1995,176(2):137-142
It is increasingly recognized that the identification of t(11;22)(q24;q12) is a useful aid in the accurate diagnosis of Ewing's sarcoma and related tumours. However, cytogenetic studies have a low success rate and adequate tumour is not always available. This study describes the use of fluorescence in situ hybridization (FISH) to detect translocations at 22q12, the site of the EWS gene involved in t(11;22)(q24;q12), on tumour touch imprints made from true cut core-needle biopsy and frozen tumour. Of the seven tumours analysed, five diagnosed as Ewing's sarcoma or primitive neuroectodermal tumour demonstrated chromosome translocation at 22q12. This is a rapid and reliable method to detect a diagnostically relevant chromosome translocation using minimal amounts of fresh or frozen tumour. 相似文献